HemaSphere (Jun 2022)

P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON

  • M. Delforge,
  • S. Z. Usmani,
  • N. W. van de Donk,
  • A. L. Garfall,
  • P. Moreau,
  • A. Oriol,
  • A. K. Nooka,
  • L. Rosinol,
  • N. Bahlis,
  • P. Rodriguez-Otero,
  • T. Martin,
  • J. Diels,
  • S. Van Sanden,
  • L. Pei,
  • E. Ammann,
  • R. Kobos,
  • M. Slavcev,
  • J. Smit,
  • A. Londhe,
  • A. Krishnan

DOI
https://doi.org/10.1097/01.HS9.0000846464.96684.8e
Journal volume & issue
Vol. 6
pp. 789 – 790

Abstract

Read online

No abstracts available.